Literature DB >> 8192747

T cell lymphoid aggregates in bone marrow in idiopathic hypereosinophilic syndrome.

J Metz1, K M McGrath, H F Savoia, C G Begley, R Chetty.   

Abstract

Idiopathic hypereosinophilic syndrome (HES) comprises a heterogeneous group of disorders characterised by prolonged eosinophilia with no obvious cause. A patient with longstanding HES is reported in whom unusual non-neoplastic peritrabecular lymphoid aggregates were present in the bone marrow, a hitherto undescribed association, as far as is known. An eosinophil colony stimulating activity was detected in the serum. The findings in this patient provide further evidence for an important role for eosinophil colony stimulating activity interleukin-5 mediated T lymphocyte control of eosinophil production in the pathogenesis of the HES.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8192747      PMCID: PMC501627          DOI: 10.1136/jcp.46.10.955

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Lymphomatoid papulosis and its relationship to "idiopathic" hypereosinophilic syndrome.

Authors:  S J Whittaker; R R Jones; C J Spry
Journal:  J Am Acad Dermatol       Date:  1988-02       Impact factor: 11.527

2.  Löffler's endomyocardial fibrosis with eosinophilia in association with acute lymphoblastic leukemia.

Authors:  P M Blatt; G Rothstein; H L Miller; W J Cathey
Journal:  Blood       Date:  1974-10       Impact factor: 22.113

Review 3.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

4.  Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome.

Authors:  J B Harley; A S Fauci; H R Gralnick
Journal:  Am J Cardiol       Date:  1983-08       Impact factor: 2.778

5.  The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients.

Authors:  D Catovsky; C Bernasconi; P J Verdonck; A Postma; J Hows; A van der Does-van den Berg; J K Rees; G Castelli; E Morra; D A Galton
Journal:  Br J Haematol       Date:  1980-08       Impact factor: 6.998

6.  Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma.

Authors:  C J Kim; S H Park; J G Chi
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

7.  Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.

Authors:  W F Owen; M E Rothenberg; J Petersen; P F Weller; D Silberstein; A L Sheffer; R L Stevens; R J Soberman; K F Austen
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

8.  Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.

Authors:  A F Lopez; C G Begley; D J Williamson; D J Warren; M A Vadas; C J Sanderson
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  8 in total
  4 in total

1.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  T cell lymphoid aggregates in idiopathic hypereosinophilic syndrome.

Authors:  D Slater
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

3.  T cells in idiopathic hypereosinophilic syndrome.

Authors:  D N Slater
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

Review 4.  Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.

Authors:  K Tajima; T Katagiri
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.